JP2009502779A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502779A5
JP2009502779A5 JP2008522759A JP2008522759A JP2009502779A5 JP 2009502779 A5 JP2009502779 A5 JP 2009502779A5 JP 2008522759 A JP2008522759 A JP 2008522759A JP 2008522759 A JP2008522759 A JP 2008522759A JP 2009502779 A5 JP2009502779 A5 JP 2009502779A5
Authority
JP
Japan
Prior art keywords
hgh
complex
biocompatible polymer
peg
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008522759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009502779A (ja
Filing date
Publication date
Priority claimed from US11/187,522 external-priority patent/US20050281778A1/en
Application filed filed Critical
Publication of JP2009502779A publication Critical patent/JP2009502779A/ja
Publication of JP2009502779A5 publication Critical patent/JP2009502779A5/ja
Pending legal-status Critical Current

Links

JP2008522759A 2005-07-22 2005-12-20 生体適合性ポリマーに結合させたヒト成長ホルモン Pending JP2009502779A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/187,522 US20050281778A1 (en) 2003-03-28 2005-07-22 Human growth hormone conjugated with biocompatible polymer
PCT/US2005/046791 WO2007018583A2 (en) 2005-07-22 2005-12-20 Human growth hormone conjugated with biocompatible polymer

Publications (2)

Publication Number Publication Date
JP2009502779A JP2009502779A (ja) 2009-01-29
JP2009502779A5 true JP2009502779A5 (cg-RX-API-DMAC10.html) 2009-03-12

Family

ID=36808363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008522759A Pending JP2009502779A (ja) 2005-07-22 2005-12-20 生体適合性ポリマーに結合させたヒト成長ホルモン

Country Status (7)

Country Link
US (1) US20050281778A1 (cg-RX-API-DMAC10.html)
EP (1) EP1915179A2 (cg-RX-API-DMAC10.html)
JP (1) JP2009502779A (cg-RX-API-DMAC10.html)
KR (1) KR20080041661A (cg-RX-API-DMAC10.html)
AU (1) AU2005335186A1 (cg-RX-API-DMAC10.html)
CA (1) CA2616187A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007018583A2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547445B2 (en) * 1998-03-19 2009-06-16 Surmodics, Inc. Crosslinkable macromers
US20060233740A1 (en) * 2005-03-23 2006-10-19 Bossard Mary J Conjugates of an hGH moiety and a polymer
JP5458416B2 (ja) * 2008-04-03 2014-04-02 バイオスティード ジーン エクスプレッション テック. カンパニー リミテッド 二本鎖ポリエチレングリコール化成長ホルモン、その製造方法およびその使用
US10064951B2 (en) 2012-03-30 2018-09-04 Hanmi Science Co., Ltd. Liquid formulation of highly concentrated long-acting human growth hormone conjugate
CN116421566B (zh) * 2023-02-16 2024-10-22 高邮市人民医院 一种含聚乙二醇化重组人生长激素的制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401384B1 (en) * 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US5951974A (en) * 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates
US5597709A (en) * 1994-01-27 1997-01-28 Human Genome Sciences, Inc. Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
US5985263A (en) * 1997-12-19 1999-11-16 Enzon, Inc. Substantially pure histidine-linked protein polymer conjugates
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
OA13063A (en) * 2001-11-20 2006-11-10 Pharmacia Corp Chemically-modified human growth hormone conjugates.

Similar Documents

Publication Publication Date Title
JP2022031772A5 (cg-RX-API-DMAC10.html)
CN102026666B (zh) 促胰岛素肽缀合物制剂
CN102718858B (zh) 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
RU2006128293A (ru) Коньюгаты гормона роста человека, монопэгилированного по n-концу, способ их получения и способы их применения
EP1139753B1 (en) Formulations for treating disease and methods of using same
JP2010031018A5 (cg-RX-API-DMAC10.html)
JP2004504406A5 (cg-RX-API-DMAC10.html)
JP2022530615A5 (cg-RX-API-DMAC10.html)
JP2004501101A5 (cg-RX-API-DMAC10.html)
JP2015520128A (ja) 長時間作用性オキシントモジュリン変異体とその作製方法
RU2008143310A (ru) Способы лечения с применением цитруллина
JP2013516464A5 (cg-RX-API-DMAC10.html)
WO2003079993A3 (en) hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
WO2003055481A1 (en) Organ fibrosis inhibitors
US8324151B2 (en) Treatment of sepsis and septic shock using ghrelin and growth hormone
IL194500A (en) A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above
JP5687266B2 (ja) 大動脈線維症の治療のための組成物および方法
US10279044B2 (en) Bone fracture repair by targeting of agents that promote bone healing
JP2002522512A (ja) デキストラン−レプチン結合体、医薬組成物および関連方法
JP2005508875A5 (cg-RX-API-DMAC10.html)
JP2009528303A5 (cg-RX-API-DMAC10.html)
JP2009502779A (ja) 生体適合性ポリマーに結合させたヒト成長ホルモン
JP2002529515A5 (cg-RX-API-DMAC10.html)
JPH10509417A (ja) 妊娠した哺乳動物の高血圧を処置する方法
US20020187137A1 (en) S-methylcysteine, S-ethylcysteine, and related S-alkylthiols as antagonists to the effects of S-nitrosothiols and nitric oxide